2026 ICD-10-CM Diagnosis Code T37.0X4SPoisoning by sulfonamides, undetermined, sequela

ICD-10-CM CodesS00–T88T36-T50T37

ICD-10-CM T37.0X4S
CMSSource: CMS FY 2026 ICD-10-CM dataset · Effective Oct 1, 2025 – Sep 30, 2026

T37.0X4S is a billable ICD-10-CM diagnosis code for poisoning by sulfonamides, undetermined, sequela. The 7th character S marks it as a sequela code, which reports a problem that remains after the original condition has resolved. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 922 through 923. The code is exempt from POA reporting. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Poisoning/toxic effect/adverse effects/underdosing, sequela.

Code Identity

ICD-10-CM Code
T37.0X4S
Billable Status
Yes — Valid for Submission
Code Describes
Poisoning by sulfonamides, undetermined, sequela
Short Description
Poisoning by sulfonamides, undetermined, sequela
Same as the full description in the CMS dataset.
Parent Code
Poisoning by sulfonamides, undetermined

Code Classification

ChapterS00–T88Injury, poisoning and certain other consequences of external causes
SectionT36-T50Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances
CategoryT37Poisoning by, adverse effect of and underdosing of other systemic anti-infectives and antiparasitics
This CodeT37.0X4SPoisoning by sulfonamides, undetermined, sequela

Present on Admission (POA)Billing

T37.0X4S is exempt from POA reporting on inpatient claims to general acute care hospitals. Review other POA exempt codes.

Coding GuidelinesGuidance

When coding a poisoning or reaction to the improper use of a medication (e.g., overdose, wrong substance given or taken in error, wrong route of administration), first assign the appropriate code from categories T36-T50. The poisoning codes have an associated intent as their 5th or 6th character (accidental, intentional self-harm, assault and undetermined). If the intent of the poisoning is unknown or unspecified, code the intent as accidental intent. The undetermined intent is only for use if the documentation in the record specifies that the intent cannot be determined. Use additional code(s) for all manifestations of poisonings.

The appropriate 7th character is to be added to each code from block Poisoning by, adverse effect of and underdosing of other systemic anti-infectives and antiparasitics (T37). Use the following options for the applicable episode of care:

  • A - initial encounter
  • D - subsequent encounter
  • S - sequela

Source: ICD-10-CM Official Guidelines for Coding and Reporting, FY 2026, published by CMS and the National Center for Health Statistics.

Clinical ClassificationClinical

AHRQ’s CCSR groups this code into broader clinical categories.

CCSR INJ075
Poisoning/toxic effect/adverse effects/underdosing, sequela
Default principal diagnosis: inpatient Yes · outpatient Yes

Clinical InformationClinical

  • Acedapsone

    acetylated sulfone that is slowly metabolized to give long-term, low blood levels of dapsone. it has antimicrobial and antimalarial action, but is mainly used as a depot leprostatic agent.
  • Sulfachlorpyridazine

    a sulfonamide antimicrobial used for urinary tract infections and in veterinary medicine.
  • Silver Sulfadiazine

    antibacterial used topically in burn therapy.
  • Sulfadiazine

    one of the short-acting sulfonamides used in combination with pyrimethamine to treat toxoplasmosis in patients with acquired immunodeficiency syndrome and in newborns with congenital infections.
  • Sulfadimethoxine

    a sulfanilamide that is used as an anti-infective agent.
  • Sulfadoxine

    a long acting sulfonamide that is used, usually in combination with other drugs, for respiratory, urinary tract, and malarial infections.
  • Sulfaguanidine

    a sulfanilamide antimicrobial agent that is used to treat enteric infections.
  • Sulfalene

    long-acting plasma-bound sulfonamide used for respiratory and urinary tract infections and also for malaria.
  • Sulfamerazine

    a sulfanilamide that is used as an antibacterial agent.
  • Sulfameter

    long acting sulfonamide used in leprosy, urinary, and respiratory tract infections.
  • Sulfamethazine

    a sulfanilamide anti-infective agent. it has a spectrum of antimicrobial action similar to other sulfonamides.
  • Sulfamethizole

    a sulfathiazole antibacterial agent.
  • Sulfamethoxazole

    a bacteriostatic antibacterial agent that interferes with folic acid synthesis in susceptible bacteria. its broad spectrum of activity has been limited by the development of resistance. (from martindale, the extra pharmacopoeia, 30th ed, p208)
  • Trimethoprim, Sulfamethoxazole Drug Combination

    a drug combination with broad-spectrum antibacterial activity against both gram-positive and gram-negative organisms. it is effective in the treatment of many infections, including pneumocystis pneumonia in aids.
  • Sulfamethoxypyridazine

    a sulfanilamide antibacterial agent.
  • Sulfamonomethoxine

    long acting sulfonamide antibacterial agent.
  • Sulfamoxole

    a sulfanilamide antibacterial agent.
  • Sulfanilamide

    a short-acting sulfonamide used as an anti-infective agent. it has lower anti-bacterial activity than sulfamethoxazole.
  • Sulfanilamides

    compounds based on 4-aminobenzenesulfonamide. the '-anil-' part of the name refers to aniline.
  • Sulfaphenazole

    a sulfonilamide anti-infective agent.
  • Sulfapyridine

    antibacterial, potentially toxic, used to treat certain skin diseases.
  • Sulfasalazine

    a drug that is used in the management of inflammatory bowel diseases. its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see mesalamine) released in the colon. (from martindale, the extra pharmacopoeia, 30th ed, p907)
  • Sulfathiazole

    a sulfathiazole compound that is used as a short-acting anti-infective agent. it is no longer commonly used systemically due to its toxicity, but may still be applied topically in combination with other drugs for the treatment of vaginal and skin infections, and is still used in veterinary medicine.
  • Sulfathiazoles

    sulfanilamides consisting of a 4-aminobenzenesulfonamido group at the 2-position of 1,3-thiazole. they are often used as anti-infective agents.
  • Sulfisomidine

    a sulfanilamide antibacterial agent.
  • Sulfisoxazole

    a short-acting sulfonamide antibacterial with activity against a wide range of gram- negative and gram-positive organisms.

Table of Drugs and ChemicalsClinical

Substances in the Table of Drugs and Chemicals that reference this code family. Always confirm in the Tabular List before coding.

SubstanceAccidentalSelf-harmAssaultUndeter­minedAdverse
Effect
Under­dosing
AcedapsoneT37.0X1T37.0X2T37.0X3T37.0X4T37.0X5T37.0X6
AcesulfamethoxypyridazineT37.0X1T37.0X2T37.0X3T37.0X4T37.0X5T37.0X6
AcetylsulfamethoxypyridazineT37.0X1T37.0X2T37.0X3T37.0X4T37.0X5T37.0X6
AzosulfamideT37.0X1T37.0X2T37.0X3T37.0X4T37.0X5T37.0X6
AzulfidineT37.0X1T37.0X2T37.0X3T37.0X4T37.0X5T37.0X6
DiaphenylsulfoneT37.0X1T37.0X2T37.0X3T37.0X4T37.0X5T37.0X6
DisulfanilamideT37.0X1T37.0X2T37.0X3T37.0X4T37.0X5T37.0X6
NeoprontosilT37.0X1T37.0X2T37.0X3T37.0X4T37.0X5T37.0X6
PhthalylsulfathiazoleT37.0X1T37.0X2T37.0X3T37.0X4T37.0X5T37.0X6
ProntosilT37.0X1T37.0X2T37.0X3T37.0X4T37.0X5T37.0X6
SalazosulfapyridineT37.0X1T37.0X2T37.0X3T37.0X4T37.0X5T37.0X6
SalicylazosulfapyridineT37.0X1T37.0X2T37.0X3T37.0X4T37.0X5T37.0X6
SuccinylsulfathiazoleT37.0X1T37.0X2T37.0X3T37.0X4T37.0X5T37.0X6
SulfachlorpyridazineT37.0X1T37.0X2T37.0X3T37.0X4T37.0X5T37.0X6
SulfacitineT37.0X1T37.0X2T37.0X3T37.0X4T37.0X5T37.0X6
Sulfadiasulfone sodiumT37.0X1T37.0X2T37.0X3T37.0X4T37.0X5T37.0X6
SulfadiazineT37.0X1T37.0X2T37.0X3T37.0X4T37.0X5T37.0X6
Sulfadiazine::silver (topical)T37.0X1T37.0X2T37.0X3T37.0X4T37.0X5T37.0X6
SulfadimethoxineT37.0X1T37.0X2T37.0X3T37.0X4T37.0X5T37.0X6
SulfadimidineT37.0X1T37.0X2T37.0X3T37.0X4T37.0X5T37.0X6
SulfadoxineT37.0X1T37.0X2T37.0X3T37.0X4T37.0X5T37.0X6
Sulfadoxine::with pyrimethamineT37.0X1T37.0X2T37.0X3T37.0X4T37.0X5T37.0X6
SulfaethidoleT37.0X1T37.0X2T37.0X3T37.0X4T37.0X5T37.0X6
SulfafurazoleT37.0X1T37.0X2T37.0X3T37.0X4T37.0X5T37.0X6
SulfaguanidineT37.0X1T37.0X2T37.0X3T37.0X4T37.0X5T37.0X6
SulfaleneT37.0X1T37.0X2T37.0X3T37.0X4T37.0X5T37.0X6
SulfaloxateT37.0X1T37.0X2T37.0X3T37.0X4T37.0X5T37.0X6
Sulfaloxic acidT37.0X1T37.0X2T37.0X3T37.0X4T37.0X5T37.0X6
SulfamerazineT37.0X1T37.0X2T37.0X3T37.0X4T37.0X5T37.0X6
SulfameterT37.0X1T37.0X2T37.0X3T37.0X4T37.0X5T37.0X6
SulfamethazineT37.0X1T37.0X2T37.0X3T37.0X4T37.0X5T37.0X6
SulfamethizoleT37.0X1T37.0X2T37.0X3T37.0X4T37.0X5T37.0X6
SulfamethoxazoleT37.0X1T37.0X2T37.0X3T37.0X4T37.0X5T37.0X6
Sulfamethoxazole::with trimethoprimT37.0X1T37.0X2T37.0X3T37.0X4T37.0X5T37.0X6
SulfamethoxydiazineT37.0X1T37.0X2T37.0X3T37.0X4T37.0X5T37.0X6
SulfamethoxypyridazineT37.0X1T37.0X2T37.0X3T37.0X4T37.0X5T37.0X6
SulfamethylthiazoleT37.0X1T37.0X2T37.0X3T37.0X4T37.0X5T37.0X6
SulfametoxydiazineT37.0X1T37.0X2T37.0X3T37.0X4T37.0X5T37.0X6
SulfamonomethoxineT37.0X1T37.0X2T37.0X3T37.0X4T37.0X5T37.0X6
SulfamoxoleT37.0X1T37.0X2T37.0X3T37.0X4T37.0X5T37.0X6
SulfanilamideT37.0X1T37.0X2T37.0X3T37.0X4T37.0X5T37.0X6
SulfanilylguanidineT37.0X1T37.0X2T37.0X3T37.0X4T37.0X5T37.0X6
SulfaperinT37.0X1T37.0X2T37.0X3T37.0X4T37.0X5T37.0X6
SulfaphenazoleT37.0X1T37.0X2T37.0X3T37.0X4T37.0X5T37.0X6
SulfaphenylthiazoleT37.0X1T37.0X2T37.0X3T37.0X4T37.0X5T37.0X6
SulfaproxylineT37.0X1T37.0X2T37.0X3T37.0X4T37.0X5T37.0X6
SulfapyridineT37.0X1T37.0X2T37.0X3T37.0X4T37.0X5T37.0X6
SulfapyrimidineT37.0X1T37.0X2T37.0X3T37.0X4T37.0X5T37.0X6
SulfasalazineT37.0X1T37.0X2T37.0X3T37.0X4T37.0X5T37.0X6
SulfasuxidineT37.0X1T37.0X2T37.0X3T37.0X4T37.0X5T37.0X6
SulfasymazineT37.0X1T37.0X2T37.0X3T37.0X4T37.0X5T37.0X6
SulfathiazoleT37.0X1T37.0X2T37.0X3T37.0X4T37.0X5T37.0X6
SulfisomidineT37.0X1T37.0X2T37.0X3T37.0X4T37.0X5T37.0X6
SulfisoxazoleT37.0X1T37.0X2T37.0X3T37.0X4T37.0X5T37.0X6
Sulfisoxazole::ophthalmic preparationT37.0X1T37.0X2T37.0X3T37.0X4T37.0X5T37.0X6
Sulfonamide NECT37.0X1T37.0X2T37.0X3T37.0X4T37.0X5T37.0X6
Sulfonamide NEC::eyeT37.0X1T37.0X2T37.0X3T37.0X4T37.0X5T37.0X6
SulphadiazineT37.0X1T37.0X2T37.0X3T37.0X4T37.0X5T37.0X6
SulphadimethoxineT37.0X1T37.0X2T37.0X3T37.0X4T37.0X5T37.0X6
SulphadimidineT37.0X1T37.0X2T37.0X3T37.0X4T37.0X5T37.0X6
SulphafurazoleT37.0X1T37.0X2T37.0X3T37.0X4T37.0X5T37.0X6
SulphamethizoleT37.0X1T37.0X2T37.0X3T37.0X4T37.0X5T37.0X6
SulphamethoxazoleT37.0X1T37.0X2T37.0X3T37.0X4T37.0X5T37.0X6
SulphaphenazoleT37.0X1T37.0X2T37.0X3T37.0X4T37.0X5T37.0X6
SulphapyridineT37.0X1T37.0X2T37.0X3T37.0X4T37.0X5T37.0X6
SulphasalazineT37.0X1T37.0X2T37.0X3T37.0X4T37.0X5T37.0X6
TrisulfapyrimidinesT37.0X1T37.0X2T37.0X3T37.0X4T37.0X5T37.0X6

Patient EducationClinical

Poisoning

A poison is any substance that is harmful to your body. You might swallow it, inhale it, inject it, or absorb it through your skin. Any substance can be poisonous if too much is taken. Poisons can include:

Read the full article at MedlinePlus

Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.

Convert T37.0X4S to ICD-9-CMHistory

The closest ICD-9-CM equivalents under the General Equivalence Mappings.

ICD-9-CM
909.0 Late eff drug poisoning
ApproximateCombination The match is approximate, and more than one code can be needed to describe the source diagnosis. Confirm with contextual judgment.
ICD-9-CM
E989 Late eff inj-undet circ
ApproximateCombination The match is approximate, and more than one code can be needed to describe the source diagnosis. Confirm with contextual judgment.

Code HistoryHistory

FY 2016AddedAdded to the ICD-10-CM code setEffective October 1, 2015, the first year of ICD-10-CM.
FY 2017–2025No changes
FY 2026CurrentCurrent code set, no changesEffective October 1, 2025 through September 30, 2026.

Questions About T37.0X4SOverview

Is T37.0X4S (Poisoning by sulfonamides, undetermined) a billable code?

Yes. This is a billable ICD-10-CM code, specific enough to report poisoning by sulfonamides, undetermined, sequela on HIPAA-covered claims from October 1, 2025 through September 30, 2026.

What does the 7th character S in T37.0X4S mean?

The final character S makes this a sequela code: it reports a lingering problem that remains after the poisoning by sulfonamides, undetermined itself has resolved, not the original event.

What MS-DRG does T37.0X4S group to?

When poisoning by sulfonamides, undetermined, sequela is the principal diagnosis on an inpatient stay, it groups to MS-DRG 922, 923, with relative weights from 1.0177 to 1.7494 depending on complications. Higher weights mean higher Medicare reimbursement.

Is T37.0X4S exempt from POA reporting?

Yes. CMS lists this code among those exempt from present on admission reporting, so hospitals do not assign a POA indicator for poisoning by sulfonamides, undetermined, sequela on inpatient claims.

What is the ICD-9 equivalent of T37.0X4S?

Under the General Equivalence Mappings, poisoning by sulfonamides, undetermined, sequela converts to ICD-9-CM 909.0 (late eff drug poisoning) and E989 (late eff inj-undet circ). The mapping is approximate, so confirm the match fits the documentation.

Footnotes

[1] Not chronic - A diagnosis code that does not fit the criteria for chronic condition (duration, ongoing medical treatment, and limitations) is considered not chronic. Some codes designated as not chronic are acute conditions. Other diagnosis codes that indicate a possible chronic condition, but for which the duration of the illness is not specified in the code description (i.e., we do not know the condition has lasted 12 months or longer) also are considered not chronic.